Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs

Journal of Bone and Mineral Research

Volumn 20, Issue 9, 2005, Pages 1680-1691

  Liu, Yan ^a   Shen, Qi ^a   Malloy, Peter J ^b   Soliman, Emad ^a   Peng, Xiaorong ^a   Kim, Sungtae ^c   Pike, J Wesley ^c   Feldman, David ^b   Christakos, Sylvia ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Phosphorylation; Transcription; Vitamin D receptor

Indexed keywords

1,25 DIHYDROXY 16,23 DIENE 26,27 HEXAFLUORO 19 NORVITAMIN D3; 21 (3 HYDROXY 3 METHYLBUTYL) 23 YNE 26,27 HEXAFLUORO 19 NOR 1,25 DIHYDROXYVITAMIN D3; CALCITRIOL; CALCITRIOL DERIVATIVE; NUCLEAR RECEPTOR COACTIVATOR 2; OKADAIC ACID; RO 26 2198; RO 4383561; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D DERIVATIVE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE INACTIVATION; GENE MUTATION; GENETIC DISORDER; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIGAND BINDING; NONHUMAN; PATIENT SELECTION; PROTEIN PHOSPHORYLATION; RARE DISEASE; RAT; RECEPTOR UPREGULATION; REPORTER GENE; TRANSCRIPTION REGULATION; VITAMIN D RESISTANT RICKETS;

ANIMALS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL LINE; CERCOPITHECUS AETHIOPS; CHROMATIN IMMUNOPRECIPITATION; COS CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBROBLASTS; GENES, REPORTER; GLUTATHIONE TRANSFERASE; LIGANDS; MICE; MUTATION; NERVE TISSUE PROTEINS; OKADAIC ACID; OSTEOBLASTS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, CALCITRIOL; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RICKETS; RNA; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; VITAMIN D;

EID: 24144448951     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.050410     Document Type: Article

References (45)

1. Freedman LP 1999 Increasing the complexity of coactivation in nuclear receptor signaling. Cell 97:5-8.
2. Rachez C, Freedman LP 2000 Mechanisms of gene regulation by vitamin D(3) receptor: A network of coactivator interactions. Gene 246:9-21.
3. Rochel N, Wurtz JM, Mitschler A, Klaholz B, Moras D 2000 The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell 5:173-179.
4. Christakos S, Dhawan P, Liu Y, Peng X, Porta A 2003 New insights into the mechanisms of vitamin D action. J Cell Biochem 88:695-705.
5. McKenna NJ, Xu J, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW 1999 Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol 69:3-12.
6. Rachez C, Lemon BD, Suldan Z, Bromleigh V, Gamble M, Naar AM, Erdjument-Bromage H, Tempst P, Freedman LP 1999 Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398:824-828.
7. Pike JW, Sleator NM 1985 Hormone-dependent phosphorylation of the 1,25-dihydroxyvitamin D3 receptor in mouse fibroblasts. Biochem Biophys Res Commun 131:378-385.
8. Brown TA, DeLuca HF 1990 Phosphorylation of the 1,25-dihydroxyvitamin D3 receptor. A primary event in 1,25-dihydroxyvitamin D3 action. J Biol Chem 265:10025-10029.
9. Jurutka PW, Hsieh JC, Haussler MR 1993 Phosphorylation of the human 1,25-dihydroxyvitamin D3 receptor by cAMP-dependent protein kinase, in vitro, and in transfected COS-7 cells. Biochem Biophys Res Commun 191:1089-1096.
10. Hsieh JC, Jurutka PW, Galligan MA, Terpening CM, Haussler CA, Samuels DS, Shimizu Y, Shimizu N, Haussler MR 1991 Human vitamin D receptor is selectively phosphorylated by protein kinase C on serine 51, a residue crucial to its transactivation function. Proc Natl Acad Sci USA 88:9315-9319.
11. Jurutka PW, Hsieh JC, MacDonald PN, Terpening CM, Haussler CA, Haussler MR, Whitfield GK 1993 Phosphorylation of serine 208 in the human vitamin D receptor. The predominant amino acid phosphorylated by casein kinase II, in vitro, and identification as a significant phosphorylation site in intact cells. J Biol Chem 268:6791-6799.
12. Ait-Si-Ali S, Carlisi D, Ramirez S, Upegui-Gonzalez LC, Duquel A, Robin P, Rudkin B, Harel-Bellan A, Trouche D 1999 Phosphorylation by p44 MAP Kinase/ERK1 stimulates CBP histone acetyl transferase activity in vitro. Biochem Biophys Res Commun 262:157-162.
13. Janknecht R, Nordheim A 1996 MAP kinase-dependent transcriptional coactivation by Elk-1 and its cofactor CBP. Biochem Biophys Res Commun 228:831-837.
14. Rowan BG, Garrison N, Weigel NL, O'Malley BW 2000 8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein. Mol Cell Biol 20:8720-8730.
15. Malloy PJ, Pike JW, Feldman D 1999 The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr Rev 20:156-188.
16. Kristjansson K, Rut AR, Hewison M, O'Riordan JL, Hughes MR 1993 Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25 dihydroxyvitamin D3. J Clin Invest 92:12-16.
17. Whitfield GK, Selznick SH, Haussler CA, Hsieh JC, Galligan MA, Jurutka PW, Thompson PD, Lee SM, Zerwekh JE, Haussler MR 1996 Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: Point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner. Mol Endocrinol 10:1617-1631.
18. Malloy PJ, Eccleshall TR, Gross C, Van Maldergem L, Bouillon R, Feldman D 1997 Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness. J Clin Invest 99:297-304.
19. Malloy PJ, Zhu W, Zhao XY, Pehling GB, Feldman D 2001 A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets. Mol Genet Metab 73:138-148.
20. Barletta F, Freedman LP, Christakos S 2002 Enhancement of VDR-mediated transcription by phosphorylation: Correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex. Mol Endocrinol 16:301-314.
21. Kerry DM, Dwivedi PP, Hahn CN, Morris HA, Omdahl JL, May BK 1996 Transcriptional synergism between vitamin D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase (CYP24) promoter. J Biol Chem 271:29715-29721.
22. Zou A, Elgort MG, Allegretto EA 1997 Retinoid X receptor (RXR) ligands activate the human 25-hydroxyvitamin D3-24-hydroxylase promoter via RXR heterodimer binding to two vitamin D-responsive elements and elicit additive effects with 1,25-dihydroxyvitamin D3. J Biol Chem 272:19027-19034.
23. Malloy PJ, Xu R, Peng L, Clark PA, Feldman D 2002 A novel mutation in helix 12 of the vitamin D receptor impairs coactivator interaction and causes hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia. Mol Endocrinol 16:2538-2546.
24. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K 1995 Current Protocols in Molecular Biology. Wiley, New York, NY, USA.
25. Gorman CM, Moffat LF, Howard BH 1982 Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2:1044-1051.
26. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
27. Yang W, Freedman LP 1999 20-Epi analogues of 1,25-dihydroxyvitamin D3 are highly potent inducers of DRIP coactivator complex binding to the vitamin D3 receptor. J Biol Chem 274:16838-16845.
28. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M 2000 Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852.
29. Yamamoto H, Shevde NK, Warrier A, Plum LA, DeLuca HF, Pike JW 2003 2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts. J Biol Chem 278:31756-31765.
30. Malloy PJ, Xu R, Peng L, Peleg S, Al-Ashwal A, Feldman D 2004 Hereditary 1,25-dihydroxyvitamin D resistant rickets due to a mutation causing multiple defects in vitamin D receptor function. Endocrinology 145:5106-5114.
31. Uskokovic MR, Norman AW, Manchand PS, Studzinski GP, Campbell MJ, Koeffler HP, Takeuchi A, Siu-Caldera ML, Rao DS, Reddy GS 2001 Highly active analogs of 1alpha,25-dihydroxyvitamin D(3) that resist metabolism through C-24 oxidation and C-3 epimerization pathways. Steroids 66:463-471.
32. Weyts FA, Dhawan P, Zhang X, Bishop JE, Uskokovic MR, Ji Y, Studzinski GP, Norman AW, Christakos S 2004 Novel Gemini analogs of lalpha,25- dihydroxyvitamin D(3) with enhanced transcriptional activity. Biochem Pharmacol 67:1327-1336.
33. Masuyama H, Brownfield CM, St-Arnaud R, MacDonald PN 1997 Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Mol Endocrinol 11:1507-1517.
34. Rachez C, Suldan Z, Ward J, Chang CP, Burakov D, Erdjument-Bromage H, Tempst P, Freedman LP 1998 A novel protein complex that interacts with the vitamin D3 receptor in a ligand dependent manner and enhances VDR transactivation in a cell free system. Genes Dev 15:1787-1800.
35. Beck CA, Weigel NL, Edwards DP 1992 Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors. Mol Endocrinol 6:607-620.
36. Moyer ML, Borror KC, Bona BJ, DeFranco DB, Nordeen SK 1993 Modulation of cell signaling pathways can enhance or impair glucocorticoid-induced gene expression without altering the state of receptor phosphorylation. J Biol Chem 268:22933-22940.
37. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M, Evans RM 1996 Role of CBP/P300 in nuclear receptor signalling. Nature 383:99-103.
38. Schwartz C, Beck K, Mink S, Schmolke M, Budde B, Wenning D, Klempnauer KH 2003 Recruitment of p300 by C/EBPbeta triggers phosphorylation of p300 and modulates coactivator activity. EMBO J 22:882-892.
39. Kovacs KA, Steinmann M, Magistretti PJ, Halfen O, Cardinaux JR 2003 CCAAT/enhancer-binding protein family members recruit the coactivator CREB-binding protein and trigger its phosphorylation. J Biol Chem 278:36959-36965.
40. Impey S, Fong AL, Wang Y, Cardinaux JR, Pass DM, Obrietan K, Wayman GA, Storm DR, Soderling TR, Goodman RH 2002 Phosphorylation of CBP mediates transcriptional activation by neural activity and CaM kinase IV. Neuron 34:235-244.
41. Font de Mora J, Brown M 2000 AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol 20:5041-5047.
42. Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ, Kumar R 2000 Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun 270:701-708.
43. Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L 2002 A 1alpha,25-dihydroxyvitamin D (3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51:1367-1374.
44. Issa LL, Leong GM, Sutherland RL, Eisman JA 2002 Vitamin D analogue-specific recruitment of vitamin D receptor coactivators. J Bone Miner Res 17:879-890.
45. Gardezi SA, Nguyen C, Malloy PJ, Posner GH, Feldman D, Peleg S 2001 A rationale for treatment of hereditary vitamin D-resistant rickets with analogs of 1a,25-dihydroxyvitamin D3. J Biol Chem 276:29148-29156.